We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

71 hedge funds and large institutions have $53.8M invested in T2 Biosystems, Inc in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 17

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

15% less funds holding

Funds holding: 8471 (-13)

19% less capital invested

Capital invested by funds: $66.2M → $53.8M (-$12.3M)

45% less call options, than puts

Call options by funds: $236K | Put options by funds: $431K

57% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 21

Holders
71
Holders Change
-13
Holders Change %
-15.48%
% of All Funds
1.54%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
22
Reduced
17
Closed
21
Calls
$236K
Puts
$431K
Net Calls
-$195K
Net Calls Change
-$94K
Name Holding Trade Value Shares
Change
Change in
Stake
Federated Hermes
76
Federated Hermes
Pennsylvania
$1K
First Manhattan
77
First Manhattan
New York
$1K
FNC
78
First National Corp
Massachusetts
$1K
NFG
79
Next Financial Group
Texas
$1K
NFH
80
NEXT Financial Holdings
Texas
$1K
TM
81
Tiger Management
New York
-$2.47M -164 Closed
CAM
82
ClariVest Asset Management
California
-$574K -38 Closed
OAM
83
Oxford Asset Management
United Kingdom
-$558K -37 Closed
Renaissance Technologies
84
Renaissance Technologies
New York
-$502K -33 Closed
EMFAT
85
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$468K -31 Closed
Assenagon Asset Management
86
Assenagon Asset Management
Luxembourg
-$381K -25 Closed
SSA
87
Schonfeld Strategic Advisors
New York
-$321K -21 Closed
Squarepoint
88
Squarepoint
New York
-$162K -11 Closed
Two Sigma Investments
89
Two Sigma Investments
New York
-$157K -10 Closed
Citadel Advisors
90
Citadel Advisors
Florida
-$136K -8 Closed
QSS
91
Quantitative Systematic Strategies
Florida
-$89K -6 Closed
SWM
92
SeaCrest Wealth Management
New York
-$89K -6 Closed
Manulife (Manufacturers Life Insurance)
93
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$72K -5 Closed
Jane Street
94
Jane Street
New York
-$67K -4 Closed
PAG
95
Private Advisor Group
New Jersey
-$45K -3 Closed
PIA
96
Phoenix Investment Adviser
New York
-$24K -2 Closed
Walleye Trading
97
Walleye Trading
New York
-$36K -2 Closed
WAM
98
Weiss Asset Management
Massachusetts
-$37K -2 Closed
IA
99
IFP Advisors
Florida
-$11K -1 Closed
MWNA
100
Marshall Wace North America
New York
-$22K -1 Closed

TTOO Hedge Fund Activity: Q1 2019 in Review

71 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q1 2019, worth a combined $53.8M — down 19% from $66.2M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of TTOO and 9 opened new positions — a net loss of 12 holders — while 17 trimmed existing stakes and 22 added.

The largest buyer was BlackRock, adding an estimated $1.45M. The largest seller was Tiger Management, exiting entirely with an estimated $2.47M sold.

  • 71 institutional investors held T2 Biosystems, Inc (TTOO) as of Q1 2019, down from 84 in Q4 2018.
  • Funds reported $53.8M of T2 Biosystems, Inc stock for Q1 2019, down 19% quarter-over-quarter.
  • 9 funds opened new T2 Biosystems, Inc positions in Q1 2019 and 21 closed out, a net change of -12 holders.
  • The largest T2 Biosystems, Inc buyer in Q1 2019 was BlackRock, an estimated $1.45M added.
  • The largest T2 Biosystems, Inc seller in Q1 2019 was Tiger Management, an estimated $2.47M sold.

Based on aggregated 13F filings for Q1 2019.